Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Seth Klarman, latest 13F

Seth Klarman · Q4 2016

Baupost Group

Portfolio at the end of Q4 2016, from the 13F filed February 14, 2017. See the filing on EDGAR ↗

CompanyWeightValueSharesPriceHeld sinceChange
Cheniere Energy LNG · history 11.7% $900.1M 21,726,340 $41.43 Q1 2014 Reduce 22%
Viasat VSAT · history 11.4% $871.3M 13,158,137 $66.22 Q2 2013 or earlier Add 14%
Synchrony SYF · history 9.8% $749.5M 20,665,000 $36.27 Q3 2016 Add 18%
Allergan AGN · history 9.4% $720.9M 3,432,603 $210.01 Q1 2016 Add 71%
Twenty-First Century Fox FOXA · history 7.0% $536.6M 19,137,469 $28.04 Q3 2015 Add 50%
PBF Energy PBF · history 5.7% $438.4M 15,724,175 $27.88 Q3 2013 No change
Dell Technologies DELL · history 4.8% $365.7M 6,652,459 $54.97 Q3 2016 No change
Antero Resources AR · history 4.5% $343.1M 14,505,881 $23.65 Q3 2014 No change
Theravance Biopharma TBPH · history 3.9% $295.7M 9,273,991 $31.88 Q2 2014 Add 26%
NorthStar Asset Management NSAM · history 3.6% $279.1M 18,705,000 $14.92 Q3 2016 Add 89%
NorthStar Realty Finance NRF · history 2.9% $220.8M 14,577,134 $15.15 Q3 2016 Add 165%
Twenty-First Century Fox FOX · history 2.6% $198.3M 7,278,100 $27.25 Q3 2015 No change
Veritiv VRTV · history 2.1% $163.6M 3,044,385 $53.75 Q3 2014 No change
Innoviva INVA · history 2.1% $159.8M 14,931,483 $10.70 Q2 2013 or earlier No change
Keryx Biopharmaceuticals KERX · history 2.0% $151.1M 25,791,678 $5.86 Q1 2014 No change
Colony Financial CLNY · history 1.8% $140.9M 6,959,017 $20.25 Q3 2016 Add 57%
McKesson MCK · history 1.8% $140.4M 1,000,000 $140.45 Q4 2016 Buy
Forward Pharma FWP · history 1.0% $80.5M 5,367,300 $15.00 Q4 2014 No change
Atara Biotherapeutics ATRA · history 1.0% $76.1M 5,359,632 $14.20 Q4 2014 No change
Cardinal Health CAH · history 1.0% $74.1M 1,030,000 $71.97 Q4 2016 Buy
Atlanta Braves Holdings BATRK · history 0.8% $61.6M 2,994,010 $20.59 Q2 2016 No change
American International Group AIG.WS · warrants · history 0.8% $60.9M 2,594,317 $23.46 Q2 2013 or earlier No change
Syngenta SYT · history 0.8% $58.9M 745,136 $79.05 Q4 2016 Buy
Liberty Ventures LVNTA · history 0.7% $54.6M 1,481,719 $36.87 Q4 2016 Buy
Credit Acceptance CACC · history 0.7% $53.2M 244,400 $217.51 Q2 2016 Add 144%
ChipMOS IMOS · history 0.6% $49.5M 3,509,858 $14.11 Q2 2013 or earlier Reduce 6%
GTY Technology GTYH.U · units · history 0.6% $46.2M 4,400,000 $10.50 Q4 2016 Buy
Permian Resources CDEV · history 0.6% $43.6M 2,407,153 $18.10 Q4 2016 Buy
Novagold Resources NG · history 0.6% $43.3M 9,500,000 $4.56 Q2 2013 or earlier No change
Cencora COR · history 0.5% $39.3M 502,474 $78.19 Q4 2016 Buy
Innoviva INVA.CV · convertible notes · history 0.5% $38.4M 46,230,000 prn Q3 2014 Reduce 4%
Conyers Park Acquisition CPAA · history 0.5% $38.0M 3,712,500 $10.23 Q3 2016 No change
Theravance Biopharma TBPH.CV · convertible notes · history 0.4% $34.1M 30,000,000 prn Q4 2016 Buy
Paratek Pharmaceuticals PRTK · history 0.4% $31.5M 2,044,498 $15.40 Q4 2014 No change
Saban Capital Acquisition SCAC · history 0.3% $23.3M 2,326,500 $10.00 Q4 2016 Buy
Cascadian Therapeutics CASC · history 0.2% $18.0M 4,166,666 $4.31 Q2 2016 Reduce 83%
Atlanta Braves Holdings BATRA · history 0.2% $16.4M 800,000 $20.49 Q2 2016 No change
Liberty Expedia LEXEA · history 0.2% $15.7M 395,613 $39.67 Q4 2016 Buy
Sunrun RUN · history 0.2% $15.1M 2,848,082 $5.31 Q3 2015 No change
Citigroup C.WS · warrants · history 0.1% $9.6M 62,903,207 $0.15 Q2 2013 or earlier Reduce 39%
Trilogy Metals TMQ · history 0.1% $5.3M 10,600,758 $0.50 Q2 2013 or earlier No change
Orexigen Therapeutics OREX · history 0.1% $3.9M 2,226,839 $1.74 Q3 2015 No change
Conyers Park Acquisition CPAA.WS · warrants · history 0.0% $2.5M 1,237,500 $2.00 Q3 2016 No change
Saban Capital Acquisition SCAC.WS · warrants · history 0.0% $1.1M 1,163,250 $0.95 Q4 2016 Buy
44 positions100.0%$7.67B

Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q3 2016, adjusted for stock splits.

Sector weighting

Sector weights in this 13F
Health care24.3%
Energy22.5%
Media & telecom22.0%
Financials & real estate20.6%
Technology6.0%
Industrials2.3%
Materials1.4%
Consumer discretionary0.9%

What changed from Q3 2016

← Q3 2016 Q1 2017 →